» Articles » PMID: 25748615

Osteoarthritis

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2015 Mar 10
PMID 25748615
Citations 1202
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis is a major source of pain, disability, and socioeconomic cost worldwide. The epidemiology of the disorder is complex and multifactorial, with genetic, biological, and biomechanical components. Aetiological factors are also joint specific. Joint replacement is an effective treatment for symptomatic end-stage disease, although functional outcomes can be poor and the lifespan of prostheses is limited. Consequently, the focus is shifting to disease prevention and the treatment of early osteoarthritis. This task is challenging since conventional imaging techniques can detect only quite advanced disease and the relation between pain and structural degeneration is not close. Nevertheless, advances in both imaging and biochemical markers offer potential for diagnosis and as outcome measures for new treatments. Joint-preserving interventions under development include lifestyle modification and pharmaceutical and surgical modalities. Some show potential, but at present few have proven ability to arrest or delay disease progression.

Citing Articles

The comparative efficacy of L-glutamine, celecoxib, and glucosamine sulfate in osteoarthritis management.

Hu Z, Wang C, Wang C, He J, Yan Y, Xu Z Sci Rep. 2025; 15(1):8992.

PMID: 40089639 DOI: 10.1038/s41598-025-93357-y.


Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021.

Wu R, Guo Y, Chen Y, Zhang J Sci Rep. 2025; 15(1):8305.

PMID: 40065123 PMC: 11894191. DOI: 10.1038/s41598-025-93124-z.


Autologous serum supplementation promotes the phenotype maintenance of human chondrocytes with increased cellular autophagy.

Yin W, Qian Z, Liu C, Song B, Sun Q Sci Rep. 2025; 15(1):8319.

PMID: 40064928 PMC: 11894040. DOI: 10.1038/s41598-025-92071-z.


Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways.

Yanoshita M, Hirose N, Nishiyama S, Tsuboi E, Kubo N, Kita D In Vitro Cell Dev Biol Anim. 2025; .

PMID: 40064746 DOI: 10.1007/s11626-024-01008-9.


Mendelian randomization of serum micronutrients and osteoarthritis risk: focus on zinc.

Zeng W, Hong E, Ye W, Ma L, Cun D, Huang F Nutr J. 2025; 24(1):38.

PMID: 40057745 PMC: 11889886. DOI: 10.1186/s12937-025-01100-0.